BD Statement on Appointment of Dr. John Nkengasong as First Director of Africa Centers for Disease Control
Dec 9, 2016
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) today issued the following statement to congratulate Dr. John Nkengasong on his appointment as the first director of the newly established Africa Centers for Disease Control (Africa CDC).
Renuka Gadde, vice president of Global Health for BD and board member for the African Society of Laboratory Medicine (ASLM) said:
"The decision by the African Union to establish the Africa CDC will immensely benefit the continent by further enabling country-led programs to save lives and improve health and wellbeing, and John Nkengasong is the ideal person to lead this new agency.
"BD had the privilege of working in collaboration with Dr. Nkengasong in his previous positions at the United States Centers for Disease Control and Prevention, through the Labs for Life public-private sector partnership, which focuses on strengthening laboratory systems in sub-Saharan Africa and India."
Dr. Nkengasong's personal expertise, leadership and passion for improving health systems in Africa have been instrumental to the success of this program. He has also been the guiding force for the ASLM, which established a strong foundation for the advancement of laboratory medicine in sub-Saharan Africa."
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
For more information on BD, please visit bd.com.
Back to News Releases